Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen

AIMS: The purpose of this study was to clinically validate an individually planned treatment regimen for neovascular age-related macular degeneration (nAMD), termed, observe and plan. This regimen was based on the predictability of an individual's need for retreatment and aimed to reduce the cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantel, Irmela, Niderprim, Sophie-Alexia, Gianniou, Christina, Deli, Angeliki, Ambresin, Aude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145421/
https://www.ncbi.nlm.nih.gov/pubmed/24729031
http://dx.doi.org/10.1136/bjophthalmol-2013-304556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145421/
https://www.ncbi.nlm.nih.gov/pubmed/24729031
http://dx.doi.org/10.1136/bjophthalmol-2013-304556

Ejemplares similares